Effects of dendritic cells transfected with full-length wild-type p53 and stimulated by gastric cancer lysates on immune response

被引:0
|
作者
Hua-Wen Sun Qi-Bing Tang Yong-Jun Cheng Sheng-Qian Zou Department of General Surgery
机构
关键词
Effects of dendritic cells transfected with full-length wild-type p53 and stimulated by gastric cancer lysates on immune response; MHC; type; length;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
AIM:To investigate the effects of dendritic cells(DCs)transfected with full-length wild-type p53 and stimulatedby gastric cancer lysates on immune response.METHODS:The wild-type p53was transduced to DCs withadenovirus,and the DCs were stimulated by gastric cancerlysates.The surface molecules(B7-1,B7-2,MHC-Ⅰ,MHC-Ⅱ)of all DCs were detected by FACS,and the ability of the DCsto induce efficient and specific immunological response inanti-51Cr-labeled target cells was studied.BALB/c miceinjected with DCs and Mk28 were established,and CTLresponse in mice immunized with Lywt-p53DC was evaluated.Tumor-bearing mice were treated with Lywt-p53DC.RESULTS:The surface molecules of Lywt-p53DC had a highexpression of B7-1(86.70±0.07%),B7-2(18.77±0.08%),MHC-Ⅰ(87.20±0.05%)and MHC-Ⅱ(56.70±0.07%);Tlymphocytes had a specific CTL lysis ability induced by Lywt-p53DC;the CTL lysis rate was as high as 81%.The immuneprotection of Lywtp-53DC was obvious,the tumor diameterin Lywtp-53DC group was 3.10±0.31 mm,2.73±0.23mm,3.70±0.07 mm on d 13,16 and 19,respectively,whichwere smaller than control,DC,wtp53DC and LyDC group(P<0.05).Tumor growth rate in Lywtp53DC group wasslower than that in other groups(P<0.05).CONCLUSION:DCs transfected with wild-type p53 andstimulated by gastric cancer lysates have specific CTL killingactivity.
引用
收藏
页码:2595 / 2597
页数:3
相关论文
共 50 条
  • [41] Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53
    YonishRouach, E
    Deguin, V
    Zaitchouk, T
    Breugnot, C
    Mishal, Z
    Jenkins, JR
    May, E
    ONCOGENE, 1995, 11 (11) : 2197 - 2205
  • [42] Wild-type p53 activates SAP expression in lymphoid cells
    N Nagy
    M Takahara
    J Nishikawa
    J C Bourdon
    L L Kis
    G Klein
    E Klein
    Oncogene, 2004, 23 : 8563 - 8570
  • [43] Wild-type p53 activates SAP expression in lymphoid cells
    Nagy, N
    Takahara, M
    Nishikawa, J
    Bourdon, JC
    Kis, LL
    Klein, G
    Klein, E
    ONCOGENE, 2004, 23 (53) : 8563 - 8570
  • [44] Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-type versus Mutant p53
    Tang, Yaxiong
    Simoneau, Anne R.
    Xie, Jun
    Shahandeh, Babbak
    Zi, Xiaolin
    CANCER PREVENTION RESEARCH, 2008, 1 (06) : 439 - 451
  • [45] EFFECTS OF RESTORATION OF WILD-TYPE P53 EXPRESSION IN MALIGNANT KERATINOCYTES
    COURTOIS, SJ
    DEGREEF, H
    WOODWORTH, CD
    GARMYN, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) : 459 - 459
  • [46] Experimental Research on Wild-type p53 Plasmid Transfected into Retinoblastoma Cells and Tissues using an Ultrasound Microbubble Intensifier
    Luo, J.
    Zhou, X.
    Diao, L.
    Wang, Z.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (03) : 1005 - 1015
  • [47] Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection
    Namoto, M
    Yonemitsu, Y
    Nakagawa, K
    Hashimoto, S
    Kaneda, Y
    Nawata, H
    Sueishi, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (04) : 777 - 784
  • [48] RITA has growth inhibitory activity on colon cancer HCT116 cells expressing wild-type p53, but not SW480 cells harboring mutant p53, via repressing wild-type p53 ubiquitination
    Yu, Xingquan
    Han, Bing
    Guo, Song
    Hu, Baoguang
    Pan, Xiangpo
    Li, Hesheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17569 - 17578
  • [49] Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53
    York, D.
    Withers, S. S.
    Watson, K. D.
    Seo, K. W.
    Rebhun, R. B.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (03) : 1087 - 1100
  • [50] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Jean-Christophe Bourdon
    Marie P Khoury
    Alexandra Diot
    Lee Baker
    Kenneth Fernandes
    Mustapha Aoubala
    Philip Quinlan
    Colin A Purdie
    Lee B Jordan
    Anne-Catherine Prats
    David P Lane
    Alastair M Thompson
    Breast Cancer Research, 13